Tortuga Bay Puntacana Receives Condé Nast Traveler Triple Crown Recognition
05-06-2026 21:51 via prnewswire.com

Tortuga Bay Puntacana Receives Condé Nast Traveler Triple Crown Recognition

Exclusive distinction recognizes hotels featured on Condé Nast Traveler's three most prestigious lists. PUNTA CANA, Dominican Republic, June 5, 2026 /PRNewswire/ -- Tortuga Bay Puntacana, located within Puntacana Resort, has been recognized with Condé Nast Traveler's prestigious Triple...
Read more »

PR Public relations news



Ramtech VP of Business Development Kelly Williams to Speak on Modular Construction Benefits in Panel Discussion at 2026 InterFace Houston Multifamily Conference
Ramtech VP of Business Development Kelly Williams to Speak on Modular Construction Benefits in Panel Discussion at 2026 InterFace Houston Multifamily Conference
University of Phoenix researchers publish study examining doctoral students' attitudes toward AI chatbots and ChatGPT use in higher education
University of Phoenix researchers publish study examining doctoral students' attitudes toward AI chatbots and ChatGPT use in higher education
Bybit EU posiluje své postavení v Evropě před přechodem na regulaci MiCAR
Bybit EU posiluje své postavení v Evropě před přechodem na regulaci MiCAR
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
Bitmine Immersion Technologies kondigt prijsstelling aan van verhoogde aanbieding van eeuwigdurende preferente aandelen uit Serie A
Bitmine Immersion Technologies kondigt prijsstelling aan van verhoogde aanbieding van eeuwigdurende preferente aandelen uit Serie A
Bitmine Immersion Technologies gibt die Preisgestaltung für die aufgestockte Emission von unbefristeten Vorzugsaktien der Serie A bekannt
Bitmine Immersion Technologies gibt die Preisgestaltung für die aufgestockte Emission von unbefristeten Vorzugsaktien der Serie A bekannt
Bitmine Immersion Technologies annonce le prix de son offre élargie d'actions privilégiées perpétuelles de série A
Bitmine Immersion Technologies annonce le prix de son offre élargie d'actions privilégiées perpétuelles de série A
CERAVE NA PRVNÍCH CELOSVĚTOVÝCH CERAWARDS PŘIVÍTALO VÍCE NEŽ 100 OCENĚNÝCH TVŮRCŮ OBSAHU Z 22 ZEMÍ
CERAVE NA PRVNÍCH CELOSVĚTOVÝCH CERAWARDS PŘIVÍTALO VÍCE NEŽ 100 OCENĚNÝCH TVŮRCŮ OBSAHU Z 22 ZEMÍ
Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions
Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions
Bybit EU renforce son positionnement européen avant la transition vers le règlement MiCA
Bybit EU renforce son positionnement européen avant la transition vers le règlement MiCA
/C O R R E C T I O N -- U.S. Postal Service/
/C O R R E C T I O N -- U.S. Postal Service/
UGREEN unterstützt 2026 Terra Wortmann Open als offizieller Partner mit „Power für dein Spiel"
UGREEN unterstützt 2026 Terra Wortmann Open als offizieller Partner mit „Power für dein Spiel"
Desktop versie